Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Link
http://link.springer.com/article/10.1007/s13311-017-0553-8/fulltext.html
Reference66 articles.
1. Therapeutic Monoclonal Antibodies: From the bench to the clinic. Hoboken, New Jersey: John Wiley & Sons, Inc; 2009.
2. Martin R. Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis. Clin Immunol 2012;142(1):9-14.
3. Bielekova B. Daclizumab therapy for multiple sclerosis. Neurotherapeutics 2013;10(1):55-67.
4. Sheridan JP, Robinson RR, Rose JW. Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis. Expert Rev Clin Pharmacol 2014;7(1):9-19.
5. Liao W, Lin JX, Leonard WJ. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 2011;23(5):598-604.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects;Cells;2024-09-11
2. Multiple Sclerosis: Current Knowledge of the Pathology and Use of Monoclonal Antibodies as a Promising Therapy;Borneo Journal of Pharmacy;2023-11-30
3. Review on theranostic and neuroprotective applications of nanotechnology in multiple sclerosis;Journal of Drug Delivery Science and Technology;2023-03
4. Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity;Scientific Reports;2021-11-25
5. Antibody-guided design and identification of CD25-binding small antibody mimetics using mammalian cell surface display;Scientific Reports;2021-11-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3